Adastra Holdings Ltd.
Adastra Holdings Ltd.
Founded in 2014, Adastra Holdings Ltd. through its Health Canada licensed subsidiary, Adastra Labs has built a successful reputation as a leading cannabis processor. Adastra manufactures products for its successful in-house concentrates brands Phyto Extractions and Endgame Extracts and co-manufactures for many Canadian cannabis brands. With products sold at more than 2,000 retailers across the country.
Operating out of its 13,500 sq. ft. Health Canada Licensed Standard Processing and co-located analytical testing lab facility, Adastra produces and distributes cannabis-derived products designed for medical cannabis and forward-looking therapeutic use.
Adastra received its controlled substances dealer's license in August 2022 with an amendment in February 2023 and is licensed to partner with healthcare professionals and practitioners within the regulated environment to help create efficacious remedies that address the actual needs of patients.
Adastra Holdings Ltd. (XTRX)
SEDAR Information
Information d'entreprise
Capitalisation
Company Officers
Communiqués de presse
Bulletins
2021-0845 – Changement de Nom - Phyto Extractions Inc. (XTRX)
Le 31 août/August 2021
Phyto Extractions Inc. has announced a name change to Adastra Holdings Ltd.
Shares will begin trading under the new name and with a new CUSIP number on September 1, 2021.
The symbol will remain the same.
Disclosure documents are available at www.thecse.com
Please note that all open orders will be cancelled at the end of business on August 31, 2021. Dealers are reminded to re-enter their orders.
